Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chomienne

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Blood Cancer Journal|July 26, 2012
Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?E Kouroupi, J-J Kiladjian, C Dosquet, et al.
Leukemia|October 5, 2007
Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemiaJ Delaunay, N Lecomte, S Bourcier, et al.
Leukemia & Lymphoma|February 1, 1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Acta Haematologica|January 1, 1987
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literatureC Chomienne, Y Najean, L Degos, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptorsZ Chen, F Guidez, P Rousselot, et al.
Biochemical and Biophysical Research Communications|August 4, 1995
Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulationA Agadir, M Cornic, M Jérôme, et al.
Lancet (London, England)|September 23, 1989
Retinoic acid therapy for promyelocytic leukaemiaC Chomienne, P Ballerini, N Balitrand, et al.
British Journal of Haematology|April 7, 1999
Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignanciesA Parrado, R West, D Jordan, et al.
Leukemia|September 1, 1995
Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?H Dombret, S Geiger, M T Daniel, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Blood Cancer Journal|July 26, 2012
Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?E Kouroupi, J-J Kiladjian, C Dosquet, et al.
Leukemia|October 5, 2007
Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemiaJ Delaunay, N Lecomte, S Bourcier, et al.
Leukemia & Lymphoma|February 1, 1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Acta Haematologica|January 1, 1987
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literatureC Chomienne, Y Najean, L Degos, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptorsZ Chen, F Guidez, P Rousselot, et al.
Biochemical and Biophysical Research Communications|August 4, 1995
Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulationA Agadir, M Cornic, M Jérôme, et al.
Lancet (London, England)|September 23, 1989
Retinoic acid therapy for promyelocytic leukaemiaC Chomienne, P Ballerini, N Balitrand, et al.
British Journal of Haematology|April 7, 1999
Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignanciesA Parrado, R West, D Jordan, et al.
Leukemia|September 1, 1995
Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?H Dombret, S Geiger, M T Daniel, et al.
Pageof 16